3-Ethyladenine

3-Ethyladenine

SCHEMBL48200

CCn1cnc(N)c2ncnc1-2

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 9/20 0.50
ADORA1 P30542 6/20 0.50
PI4KA P42356 3/20 0.50
PI4K2B Q8TCG2 3/20 0.50
PI4K2A Q9BTU6 3/20 0.50
PI4KB Q9UBF8 3/20 0.50
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
ADORA2B P29275 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TEK Q02763 1/20 0.36
AHCY P23526 2/20 0.33
ADORA3 P0DMS8 2/20 0.33
RPS6KA5 O75582 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3-Ethyladenine SCHEMBL27631025 0.92 ADORA2A (0.44) ADORA2AADORA1PI4KAPI4K2BPI4K2A
3-Propyladenine SCHEMBL15756434 0.86 ADORA2A (0.53) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL9108201 0.83 ADORA2A (0.36) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL5513295 0.81 ADORA2A (0.35) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL13997084 0.79 ADORA2A (0.43) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL27962598 0.79 ADORA2A (0.53) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL28115671 0.78 ADORA2A (0.56) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL6673124 0.78 ADORA2A (0.39) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL6673801 0.78 ADORA2A (0.39) ADORA2AADORA1PI4KAPI4K2BPI4K2A
SCHEMBL170695 0.77 ADORA2A (0.41) ADORA2AADORA1PI4KAPI4K2BPI4K2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103823009-B Application of liquid chromatography tandem mass spectrogram method in biological monitoring of 3-alkylation adenine in mass smokers NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2015-02-18 CN claimed
CN-103822991-B Application of liquid chromatography tandem mass spectrometry method in biological monitoring on 3-ethyl adenines among samples of large-scale smokers NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2015-02-11 CN claimed
CN-103852547-B Detecting method for 3-ethyl adenine (3-HOEtA) in urine NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2015-02-11 CN claimed
CN-103808836-B Determination method of 3-alkylated adenine DNA adducts in urine NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2015-01-07 CN claimed
CN-103852547-A Detecting method for 3-ethyl adenine (3-HOEtA) in urine NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2014-06-11 CN claimed
CN-103822991-A Application of liquid chromatography tandem mass spectrometry method in biological monitoring on 3-ethyl adenines among samples of large-scale smokers NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2014-05-28 CN claimed
CN-103822988-A Application of LC (liquid chromatogram) tandem mass spectrum method in biological monitoring of N3-(2-hydroxyethyl)-adenine in large-scale smoker crowd samples NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2014-05-28 CN claimed
CN-103823009-A Application of liquid chromatography tandem mass spectrogram method in biological monitoring of 3-alkylation adenine in mass smokers NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2014-05-28 CN claimed
CN-103808836-A Determination method of 3-alkylated adenine DNA adducts in urine NAT TOBACCO QUALITY SUPERVISION & INSPECTION CT 2014-05-21 CN claimed
US-12105094-B2 Method to analyze compounds in biological samples MAGTIVIO B.V. (NL) 2024-10-01 US disclosed
EP-3548892-B1 METHOD TO ANALYZE COMPOUNDS IN BIOLOGICAL SAMPLES MAGTIVIO B V (NL) 2024-02-21 EP disclosed
US-20230393142-A1 METHOD TO ANALYZE COMPOUNDS IN BIOLOGICAL SAMPLES MAGTIVIO B.V. (NL) 2023-12-07 US disclosed
US-11774456-B2 Method to analyze compounds in biological samples magtivio b.v (NL) 2023-10-03 US disclosed
US-20220206010-A1 METHOD TO ANALYZE COMPOUNDS IN BIOLOGICAL SAMPLES magtivio b.v (NL) 2022-06-30 US disclosed
US-20100015670-A1 METHOD OF MODIFYING NUCLEOTIDE CHAIN PANASONIC CORPORATION (JP) 2010-01-21 US disclosed
EP-1647592-B1 METHOD OF MODIFYING NUCLEOTIDE CHAIN PANASONIC CORP (JP) 2009-03-11 EP disclosed
EP-2028272-A1 METHOD OF MODIFYING NUCLEOTIDE CHAIN Panasonic Corporation (JP) 2009-02-25 EP disclosed
US-20070077629-A1 Method for modifying nucleotide chain PANASONIC CORPORATION (JP) 2007-04-05 US disclosed
US-20060141523-A1 Integrated method for PCR cleanup and oligonucleotide removal APPLERA CORPORATION (US) 2006-06-29 US disclosed
EP-1647592-A1 METHOD OF MODIFYING NUCLEOTIDE CHAIN MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2006-04-19 EP disclosed